Korner BioPharma Advisors, LLC
Welcome to Korner BioPharma Advisors
KBA is a biopharmaceutical consultancy driving success from strategy to hands-on execution. We bring deep expertise across molecular modalities, therapeutic areas, and operational functions to accelerate and amplify your biopharma innovation.
“It is a privilege to apply my industry experiences in support of visionary innovators developing cutting-edge therapies.”
Paul Korner, MD, MBA
Korner BioPharma Advisors, founded in 2018 by Paul Korner, MD, MBA, is a strategic and operational consulting firm helping emerging and mid‑sized biopharmaceutical companies advance their clinical development and medical affairs goals.
Led by Paul Korner, a physician executive with over 25 years of global experience across R&D, Medical Affairs, and regulatory strategy, KBA provides expert guidance and hands-on operational support services from early development through commercialization.
With a growing network of experienced partners, KBA delivers a full complement of biopharma services—helping clients accelerate innovation, navigate regulatory complexity, and bring meaningful therapies to patients.
Expert Partners
Biostatistics
Jason Connor, PhD
Clinical Operations & PM
George Steinfels, PhD
CMC
Ishan Capila, PhD
Regulatory Affairs
Sean O'Bryan
About KBA
Deep and Broad Expertise
Therapeutic Areas
Autoimmune
Bone disease
Immuno-Oncology
Rare Disease
Urology
Women’s Health
Molecular Modalities
Biologics
Cell & Gene Therapy
Drug-Device
Peptides
Small molecules
Vaccines
Functions
Clinical Development
Medical Affairs
Safety
Regulatory Affairs
Business Development
Investor Relations
Consulting Services
Fractional CMO
R & D and portfolio strategy
Integrated operational planning
Clinical operations
Regulatory support services
Due diligence
Investor relations support
Board of Directors
KBA hands-on expertise spans a wide range of services to address the complexities of drug development